Recent Quotes (30 days)

You have no recent quotes
chg | %

Spectral Medical Inc  

(Public, TSE:EDT)   Watch this stock  
Find more results for TSE:SDI
-0.030 (-7.14%)
Oct 23 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.38 - 0.43
52 week 0.19 - 0.64
Open 0.40
Vol / Avg. 91,016.00/49,955.00
Mkt cap 80.91M
P/E     -
Div/yield     -
EPS -0.03
Shares 207.45M
Beta 1.77
Inst. own     -
Nov 9, 2017
Q3 2017 Spectral Medical Inc Earnings Release (Estimated) Add to calendar
Aug 11, 2017
Q2 2017 Spectral Medical Inc Earnings Release

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin -102.29% -286.29%
Operating margin -102.29% -288.21%
EBITD margin - -275.99%
Return on average assets -78.50% -130.46%
Return on average equity -95.49% -180.35%
Employees 23 -
CDP Score - -


135 the West Mall Unit 2
+1-416-6263233 (Phone)
+1-416-6267383 (Fax)

Website links


Spectral Medical Inc., formerly Spectral Diagnostics Inc., is a therapeutic development company. The Company is focused on the development and commercialization of a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) and the Toraymyxin (PMX) therapeutic. The Company also manufactures and sells certain reagents. The Company develops biochemical markers for the clinical syndrome known as septic shock. PMX is a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. The Company develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies through non-exclusive license and supply agreements.

Officers and directors

Anthony P. Bihl III Chairman of the Board
Paul M. Walker M.D., Ph.D. President, Chief Executive Officer, Director
Anthony Businskas Chief Financial Officer, Executive Vice President, Corporate Secretary
Gualitiero Guadagni Vice President - Sales and Marketing
Debra M. Foster RN Vice President - Clinical Development
Masayuki Kaneko Director
William Charles Stevens Director
Guillermo A. Herrera Independent Director